Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment - Stangier, J; Stähle, H; Rathgen, K (J Clin Pharmacol, 2008)
doi: https://doi.org/10.1177/0091270008324179